Business Description
Jiangsu Recbio Technology Co Ltd
ISIN : CNE1000057K9
Share Class Description:
FRA:G93: Class HTotal Employee Number:
466Compare
Compare
Traded in other countries / regions
02179.Hong KongG93.Germany IPO Date
2024-07-25Description
Jiangsu Recbio Technology Co Ltd is a vaccine company focused on the research, development, and commercialization of vaccines, with a high-value vaccine portfolio driven by in-house technologies. It has built three vaccine technology platforms: novel adjuvants, protein engineering, and immune evaluation. The company's portfolio currently consists of various vaccines, covering diseases such as cervical cancer, herpes zoster, and respiratory syncytial virus. It has two core strategic products, namely REC610, a novel adjuvanted recombinant shingles vaccine, which is currently in the stage of marketing application in China, and REC603, a recombinant HPV 9-valent vaccine under phase three clinical trial.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.28 | |||||
Equity-to-Asset | 0.31 | |||||
Debt-to-Equity | 1.35 | |||||
Debt-to-EBITDA | -1.69 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -2.26 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 15.1 | |||||
3-Year EPS without NRI Growth Rate | 9.4 | |||||
3-Year FCF Growth Rate | 15.7 | |||||
3-Year Book Growth Rate | -31.3 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 37.61 | |||||
9-Day RSI | 42.24 | |||||
14-Day RSI | 45.61 | |||||
3-1 Month Momentum % | 1.85 | |||||
6-1 Month Momentum % | 20.61 | |||||
12-1 Month Momentum % | -34.13 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.53 | |||||
Quick Ratio | 0.45 | |||||
Cash Ratio | 0.24 | |||||
Days Inventory | 12372.59 | |||||
Days Sales Outstanding | 129.48 | |||||
Days Payable | 9139.06 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -9 | |||||
Shareholder Yield % | -26.66 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 88.27 | |||||
Operating Margin % | -24845.42 | |||||
Net Margin % | -26206.66 | |||||
EBITDA Margin % | -22233.21 | |||||
FCF Margin % | -31925.88 | |||||
OCF Margin % | -26681.14 | |||||
ROE % | -105.09 | |||||
ROA % | -29.73 | |||||
ROIC % | -25.72 | |||||
3-Year ROIIC % | 51.68 | |||||
ROC (Joel Greenblatt) % | -42.57 | |||||
ROCE % | -51.21 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 1666.67 | |||||
PB Ratio | 5.43 | |||||
Price-to-Tangible-Book | 6.63 | |||||
EV-to-EBIT | -7.14 | |||||
EV-to-EBITDA | -8.02 | |||||
EV-to-Revenue | 1784.14 | |||||
EV-to-FCF | -5.59 | |||||
Earnings Yield (Greenblatt) % | -14.01 | |||||
FCF Yield % | -21.12 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Jiangsu Recbio Technology Co Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.228 | ||
| EPS (TTM) (€) | -0.097 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 47.67 | ||
| 14-Day RSI | 45.61 | ||
| 14-Day ATR (€) | 0.020021 | ||
| 20-Day SMA (€) | 0.5375 | ||
| 12-1 Month Momentum % | -34.13 | ||
| 52-Week Range (€) | 0.0635 - 0.835 | ||
| Shares Outstanding (Mil) | 626.08 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Jiangsu Recbio Technology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Jiangsu Recbio Technology Co Ltd Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Jiangsu Recbio Technology Co Ltd Frequently Asked Questions
What is Jiangsu Recbio Technology Co Ltd(FRA:G93)'s stock price today?
The current price of FRA:G93 is €0.53. The 52 week high of FRA:G93 is €0.84 and 52 week low is €0.06.
When is next earnings date of Jiangsu Recbio Technology Co Ltd(FRA:G93)?
The next earnings date of Jiangsu Recbio Technology Co Ltd(FRA:G93) is .
Does Jiangsu Recbio Technology Co Ltd(FRA:G93) pay dividends? If so, how much?
Jiangsu Recbio Technology Co Ltd(FRA:G93) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Jiangsu Recbio Technology Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers